AZD5423
Sponsors
AstraZeneca
Conditions
AsthmaBioavailability and AUCChronic Obstructive Pulmonary Disease (COPD)HealthyHealthy Volunteers
Phase 1
AZD5423 Single Ascending Dose Study
CompletedNCT00963183
Start: 2009-08-31End: 2009-11-30Target: 72Updated: 2015-01-14
AZD5423 Multiple Ascending Dose Study
CompletedNCT01037504
Start: 2010-01-31End: 2010-04-30Target: 27Updated: 2015-01-14
A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways
CompletedNCT01310322
Start: 2011-04-30End: 2011-10-31Target: 12Updated: 2015-01-14
Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects
CompletedNCT01338350
Start: 2011-06-30End: 2011-12-31Updated: 2015-01-14
A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways
CompletedNCT01635985
Start: 2012-08-31End: 2012-12-31Updated: 2015-01-14
Phase 2
The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
CompletedNCT01225549
Start: 2010-11-30End: 2011-12-31Updated: 2015-04-02
Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol
CompletedNCT01555099
Start: 2012-04-30End: 2013-04-30Updated: 2013-06-17